Technology Connecting Patients to Clinical Trials
TrialTech Medical, part of the Scarritt Group Companies portfolio, uses state of the art technology to expand trial awareness, including outreach to underrepresented patient populations.
On Average 80-85% of patients sign an ICF
Facilitation of medical records
Site support services
Minimal start up costs with no long term contract
Results based fees
Reduced coordinator workload
Continued engagement with referred patients until an ICF is signed
Real time metrics and analytics
Expanded outreach to patients with unmet medical needs
Seamless communication between study teams and TrialTech Medical
GET IN TOUCH
PHONE
GENERAL INQUIRIES
Edson.Ribeiro@ScarrittGroup.com
PHONE
GENERAL INQUIRIES